Offer - Urjas Oil for just ₹ 1 X
Trajenta Duo 2.5mg/500mg Tablet, a prescription drug, is manufactured in various forms such as Tablet. It is primarily used for the treatment of Diabetes. Trajenta Duo 2.5mg/500mg Tablet also has some secondary and off-label uses. These are listed below.
The right dosage of Trajenta Duo 2.5mg/500mg Tablet depends on the age, gender, and medical history of the patient. Individual symptoms and route of administration also determines the right dosage. For detailed information on this, read through the dosage section.
Trajenta Duo 2.5mg/500mg Tablet also has some side effects, the most common being Diarrhoea, Nausea or vomiting, Headache. Apart from the aforementioned side effects, Trajenta Duo 2.5mg/500mg Tablet can also lead to other problems, which have been listed below. Such side effects of Trajenta Duo 2.5mg/500mg Tablet normally do not last long and go away once the treatment is completed. If, however, they worsen or do not go away, please speak with your physician.
It is also important to note that Trajenta Duo 2.5mg/500mg Tablet has a Moderate effect for pregnant women and Safe effect on lactating mothers. Warnings related to Trajenta Duo 2.5mg/500mg Tablet's effects on the liver, heart and kidney, if any, have been listed below.
Trajenta Duo 2.5mg/500mg Tablet is contraindicated in people with pre-existing medical conditions like Pancreatitis, Vitamin B12 Deficiency as it can result in adverse effects.
Drug reaction of Trajenta Duo 2.5mg/500mg Tablet with other medicines has been reported. See below for a complete list.
In addition to these precautions, you may also note that Trajenta Duo 2.5mg/500mg Tablet is not safe while driving, and is is not addictive in nature.
Trajenta Duo 2.5mg/500mg Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Trajenta Duo 2.5mg/500mg Tablet safe for pregnant women?
Trajenta Duo can cause unwanted side effects in pregnant women. If you experience any side effects, stop taking Trajenta Duo right away. Take your doctor's advice before taking it again.
Is the use of Trajenta Duo 2.5mg/500mg Tablet safe during breastfeeding?
Trajenta Duo does not show any harmful effects in lactating women.
What is the effect of Trajenta Duo 2.5mg/500mg Tablet on the Kidneys?
Kidney can be affected by Trajenta Duo. If you experience any unwanted effects of this drug, stop taking it. You should take it again only after medical advice.
What is the effect of Trajenta Duo 2.5mg/500mg Tablet on the Liver?
There may be an adverse effect on the liver after taking Trajenta Duo. If you observe any side effects on your body then stop taking this drug. Take this medicine again only if your doctor advises you to do so.
What is the effect of Trajenta Duo 2.5mg/500mg Tablet on the Heart?
No research work has been carried out till date on effects of Trajenta Duo on heart. So it is not known whether taking Trajenta Duo will cause side effects on heart or not.
If you are suffering from any of the following diseases, you should not take Trajenta Duo 2.5mg/500mg Tablet unless your doctor advises you to do so -
Is this Trajenta Duo 2.5mg/500mg Tablet habit forming or addictive?
Trajenta Duo 2.5mg/500mg Tablet is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
After taking Trajenta Duo 2.5mg/500mg Tablet, you should not drive or work on any heavy machine, as Trajenta Duo 2.5mg/500mg Tablet can make you drowsy.
Is it safe?
Trajenta Duo 2.5mg/500mg Tablet is safe but it is important to consult a doctor before taking it.
Is it able to treat mental disorders?
No, Trajenta Duo 2.5mg/500mg Tablet is not used to treat mental disorders.
Interaction between Food and Trajenta Duo 2.5mg/500mg Tablet
There isn't any research available on the side effects of taking Trajenta Duo 2.5mg/500mg Tablet with food.
Interaction between Alcohol and Trajenta Duo 2.5mg/500mg Tablet
Due to lack of research, there is no information about the side effects of taking Trajenta Duo 2.5mg/500mg Tablet with alcohol.
Yes, Trajenta Duo can be taken with the statin. There is no serious or harmful interaction have been observed between them. Some studies say that it's possible your blood sugar (blood glucose) level may increase when you take a statin, which may lead to developing type 2 diabetes. The risk is small but important enough that the Food and Drug Administration (FDA) has issued a warning on statin labels regarding blood glucose levels and diabetes.
Trajenta Duo is used with a proper diet and exercise program, to treat diabetes. It is also used with other medication to reduce the high blood sugar. It is used in a patient with type2 diabetes. It is also used in the treatment of polycystic ovarian syndrome (PCOS) and cancer.
Trajenta Duo contain metformin, is an oral antidiabetic drug which belongs to the class of biguanide. It is the first-line medication for the treatment of type 2 diabetes, particularly in people who are overweight. It is also used in the treatment of polycystic ovary syndrome. Moreover, it also reduces the risk of cardiovascular complications of diabetes.
The long-term use can lead to the deficiency of Vitamin B12, which can further lead to megaloblastic anemia. Furthermore, Long-term Metformin use can also lead to kidney and liver problems.
Trajenta Duo can be taken forever, diabetes is a progressive disease it's possible that more medication and/or insulin may eventually need to be added to the regime.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Glucophage® (metformin hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 275-276
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 825-826
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 776
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Tradjenta™ (linagliptin)
Highlights of Prescribing Information [Internet]: Jentadueto™ (linagliptin and metformin hydrochloride) tablets . Initial U.S. Approval: 2012